The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Austar Lifesciences's share price is HK$0.83.
Austar Lifesciences's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$3.27. Hence, Austar Lifesciences's PS Ratio for today is 0.25.
The historical rank and industry rank for Austar Lifesciences's PS Ratio or its related term are showing as below:
HKSE:06118'
s PS Ratio Range Over the Past 10 Years
Min: 0.14 Med: 0.97 Max: 9.89
Current: 0.26
During the past 11 years, Austar Lifesciences's highest PS Ratio was 9.89. The lowest was 0.14. And the median was 0.97.
HKSE:06118's PS Ratio is ranked better than 95.56% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 3.09
vs HKSE:06118: 0.26
Austar Lifesciences Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Austar Lifesciences was -23.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 7.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 19.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 12.00% per year.
During the past 11 years, Austar Lifesciences's highest 3-Year average Revenue per Share Growth Rate was 38.60% per year. The lowest was -16.30% per year. And the median was 11.80% per year.
Back to Basics: PS Ratio
Austar Lifesciences PS Ratio Historical Data
The historical data trend for Austar Lifesciences's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Austar Lifesciences's PS Ratio
For the Medical Devices subindustry, Austar Lifesciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austar Lifesciences's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austar Lifesciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where Austar Lifesciences's PS Ratio falls into.
Austar Lifesciences PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Austar Lifesciences's Share Price of today is HK$0.83.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austar Lifesciences's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$3.27.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Austar Lifesciences (HKSE:06118) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Austar Lifesciences PS Ratio Related Terms
Thank you for viewing the detailed overview of Austar Lifesciences's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Services; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06118 has been successfully added to your 